Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,546,240
  • Shares Outstanding, K 36,030
  • Annual Sales, $ 704,590 K
  • Annual Income, $ 73,190 K
  • 60-Month Beta 1.51
  • Price/Sales 3.62
  • Price/Cash Flow 19.84
  • Price/Book 3.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.75
  • Number of Estimates 5
  • High Estimate 0.76
  • Low Estimate 0.74
  • Prior Year 0.76
  • Growth Rate Est. (year over year) -1.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
69.17 +4.62%
on 11/08/19
81.08 -10.75%
on 10/15/19
-5.68 (-7.27%)
since 10/14/19
3-Month
69.17 +4.62%
on 11/08/19
86.71 -16.54%
on 09/19/19
-4.42 (-5.75%)
since 08/14/19
52-Week
47.20 +53.32%
on 12/21/18
86.71 -16.54%
on 09/19/19
+16.68 (+29.97%)
since 11/14/18

Most Recent Stories

More News
Medpace Holdings, Inc. to Present at Credit Suisse Healthcare Conference

Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will present at the following investor conference in November:

MEDP : 72.15 (+2.09%)
Medpace (MEDP) Q3 Earnings Meet Estimates

Medpace (MEDP) delivered earnings and revenue surprises of 0.00% and -0.24%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

MEDP : 72.15 (+2.09%)
Medpace: 3Q Earnings Snapshot

CINCINNATI (AP) _ Medpace Holdings Inc. (MEDP) on Monday reported third-quarter net income of $24 million.

MEDP : 72.15 (+2.09%)
Medpace Holdings, Inc. Reports Third Quarter 2019 Results

Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced financial results for the third quarter ended September 30, 2019.

MEDP : 72.15 (+2.09%)
Medpace (MEDP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MEDP : 72.15 (+2.09%)
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?

Style Box ETF report for FYC

FYC : 45.15 (+0.04%)
LSCC : 19.46 (-1.96%)
VBK : 189.58 (+0.22%)
IWO : 202.44 (-0.02%)
SHAK : 62.41 (+0.92%)
MEDP : 72.15 (+2.09%)
Should Teladoc Worry About Amazon's Virtual Healthcare Move?

Teladoc (TDOC) might face increasing competition from Amazon in virtual healthcare space once the latter expands its presence.

LHCG : 128.94 (+1.02%)
TDOC : 78.81 (-1.13%)
MEDP : 72.15 (+2.09%)
AVDR : 22.87 (+0.09%)
The Zacks Analyst Blog Highlights: RH, PennyMac, Medpace, Mercury Systems and Lithia

The Zacks Analyst Blog Highlights: RH, PennyMac, Medpace, Mercury Systems and Lithia

LAD : 161.08 (-0.30%)
MRCY : 72.56 (+1.19%)
PFSI : 31.88 (-0.06%)
RH : 175.22 (+1.29%)
MEDP : 72.15 (+2.09%)
Medpace Holdings, Inc. to Report Third Quarter 2019 Financial Results on October 28, 2019

Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will report its third quarter 2019 financial results after the market close on Monday, October 28, 2019. The Company will host...

MEDP : 72.15 (+2.09%)
5 Must-Buy Mid-Cap Stocks Amid Global Economic Fluctuations

Investment in mid-cap stocks is often recognized as a good portfolio diversification strategy during market fluctuations.

LAD : 161.08 (-0.30%)
MRCY : 72.56 (+1.19%)
PFSI : 31.88 (-0.06%)
RH : 175.22 (+1.29%)
MEDP : 72.15 (+2.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade MEDP with:

Business Summary

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

See More

Key Turning Points

2nd Resistance Point 71.81
1st Resistance Point 71.24
Last Price 72.15
1st Support Level 70.09
2nd Support Level 69.51

See More

52-Week High 86.71
Last Price 72.15
Fibonacci 61.8% 71.62
Fibonacci 50% 66.96
Fibonacci 38.2% 62.29
52-Week Low 47.20

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar